Abstract:Objective: The purpose of the study is to investigate the rate and degree of o Design: The study design was an institutional, randomized, clinical trial. Participants: A total of 19 consecutive patients were studied. Intervention: Topical steroids were administered to Chinese children younger than 10 years of age who underwent bilateral strabismus surgery. One eye was randomized to receive topical 0.1% dexamethasone (DMS), whereas the fellow eye received 0.1% fluorometholone (FML) six times per day for up to 4 weeks. Intraocular pressure (IOP) was measured on the day before operation and at postoperative days 1, 3, 6, 10, 13, and 27, then every 2 weeks thereafter until the IOP fell to preoperative levels. Topical steroids would be stopped if IOP was 30.00 mmHg or greater. Main Outcome Measures: Peak IOP and maximal change of IOP from baseline were measured and categorized into low, intermediate, and high levels, Time to peak IOP also was studied. Results: A total of 16 patients were included. The peak IOP for DMS-treated eyes was 30.66 +/- 8.35 mmHg (range, 13.00-48.00 mmHg), whereas that in FML-treated eyes was significantly lower at 20.66 +/- 6.03 mmHg (range, 11.30-36.30 mmHg) (P = 0.001). The maximal change in IOP ranged from -2.60 to +31.00 mmHg in DMS-treated eyes (mean, 15.48 +/- 8.71 mmHg), almost double that of FML-treated eyes (range, +1.00 to +17.00 mmHg; mean, 5.83 +/- 4.96 mmHg) (P = 0.001). When the ocular-hypertensive responses of both DMS and FML groups were categorized into three levels of severity, significant differences were found between the two treatment groups (P 0.001). In the DMS group, nine patients (56.25%) were high responders and six patients (37.5%) were intermediate responders, In the FML group, only one patient (6.25%) was a high responder. Conclusions: The ocular-hypertensive response to topical DMS in children occurs more frequently, more severely, and more rapidly than that reported in adults, A total of 56% of the studied children, all younger than 10 years of age, were high responders to topical DMS. Of these, 89% attained their peak IOP within 8 days. Its use in children should best be avoided if possible. It would be desirable to monitor the IOP when it is being used. Conversely, FML produced a much less ocular-hypertensive effect and therefore poses an acceptable risk of clinically significant pressure elevation.

A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children.

Ocular-hypertensive response to topical steroids in children

Diclofenac versus fluorometholone after strabismus surgery in children

Comparative Evaluation of Topical Pranoprofen and Fluorometholone in Cases with Chronic Allergic Conjunctivitis

A Clinical Study of the Efficacy of Topical Corticosteroids on Dry Eye

Topical Fluorometholone Versus Diclofenac Sodium in Cases with Perennial Allergic Conjunctivitis.

Accelerated Ocular Hypertensive Response after Application of Corticosteroid Ointment to a Child's Eyelid

Bromfenac Sodium 0.1%, Fluorometholone 0.1% and Dexamethasone 0.1% for Control of Ocular Inflammation and Prevention of Cystoid Macular Edema after Phacoemulsification

Combination Therapy of 0.1% Fluorometholone and 0.05% Azelastine in Eyes with Severe Allergic Conjunctival Diseases: A Randomized Controlled Trial

The generation of fluorometholone nanocrystal eye drops, their metabolization to dihydrofluorometholone and penetration into rabbit eyes

A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.

Corticosteroid-induced intraocular pressure elevation in the pediatric patients: A protocol for systematic review

Effects of 0.02%fluorometholone combined with hyaluronate on the treatment of systemic lupus erythemato-sus(SLE)related dry eye

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

[Randomized Parallel Group Study of 0.0015% Tafluprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension (comparison with 0.005% Latanoprost Ophthalmic Solution)].

Efficacy and Safety of Loteprednol Etabonate Versus Fluorometholone in the Treatment of Patients after Corneal Refractive Surgery: a Meta-Analysis

Effect of co-administration of pranoprofen/emedastine difumarate eye drops on efficacy, inflammatory factors, tear film stability and immune function in children with allergic conjunctivitis

Risk of intraocular pressure elevation after topical steroids in children and adults: A systematic review

Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid‐dependent nephrotic syndrome

Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial

Adverse Effect Profile of Topical Ocular Administration of Fingolimod for Treatment of Dry Eye Disease.